Nuveen Real Asset Income and Growth Fund (JRI) to Issue Monthly Dividend of $0.13 on July 1st

Nuveen Real Asset Income and Growth Fund (NYSE:JRIGet Free Report) declared a monthly dividend on Monday, June 1st. Shareholders of record on Monday, June 15th will be given a dividend of 0.1335 per share on Wednesday, July 1st. This represents a c) dividend on an annualized basis and a yield of 12.5%. The ex-dividend date is Monday, June 15th.

Nuveen Real Asset Income and Growth Fund Stock Performance

Nuveen Real Asset Income and Growth Fund stock opened at $12.84 on Friday. Nuveen Real Asset Income and Growth Fund has a 1 year low of $11.67 and a 1 year high of $14.37. The company’s 50-day moving average is $12.86 and its two-hundred day moving average is $13.08.

About Nuveen Real Asset Income and Growth Fund

(Get Free Report)

Nuveen Real Asset Income and Growth Fund (NYSE: JRI) is a diversified, closed-end management investment company managed by Nuveen Advisors, LLC. The fund seeks to deliver a combination of income and capital growth by investing primarily in securities tied to real assets, including real estate investment trusts, infrastructure funds, master limited partnerships and other real asset-related equities. Launched on March 1, 2007, JRI provides investors with exposure to physical assets that can serve as an inflation hedge while pursuing consistent distribution streams.

The fund employs an active, research-driven approach to portfolio management, targeting high-quality issuers whose businesses benefit from long-term demand trends in sectors such as utilities, energy infrastructure, transportation and agriculture.

Featured Stories

Dividend History for Nuveen Real Asset Income and Growth Fund (NYSE:JRI)

Receive News & Ratings for Nuveen Real Asset Income and Growth Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen Real Asset Income and Growth Fund and related companies with MarketBeat.com's FREE daily email newsletter.